Recent histology and PET imaging studies have confirmed that these clinical variants exhibit distinct patterns of tau pathology (Nelson et al., 2012; Ossenkoppele et al., 2016; Petersen et al., 2019), highlighting the importance of disentangling tau pathology heterogeneity for better profiling, diagnosis, and targeted treatment of AD. Here, MAPT is linked to Alzheimer disease.